Margaret Kolb

Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases

Mark A. Socinski, Corey J. Langer, Jane E. Huang et al. · Journal of Clinical Oncology · 2009 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer

Alan Sandler, Jing Yi, Suzanne E. Dahlberg et al. · Journal of Thoracic Oncology · 2010 · 172 citations · Full text

Medicine, Oncology, Pharmacology +8

Safety and Efficacy of Combining Sunitinib with Bevacizumab + Paclitaxel/Carboplatin in Non-small Cell Lung Cancer

Mark A. Socinski, Frank A. Scappaticci, Meghna Samant et al. · Journal of Thoracic Oncology · 2010 · 45 citations · Full text

Medicine, Oncology, Pharmacology +12

A phase III, randomized, open-label, multicenter, global study of durvalumab and bacillus calmette-guérin (BCG) versus BCG alone in high-risk, BCG-naïve non-muscle-invasive bladder cancer (NMIBC) patients (POTOMAC).

Maria De Santis, Ramil Abdrashitov, Axel Hegele et al. · Journal of Clinical Oncology · 2019 · 20 citations

Medicine, Oncology, Pharmacology +15